BHE's relationships offer a way to participate in AI infrastructure spending, with opportunities extending from product development into manufacturing. They're also nearshoring capacity and recovering end markets. This helps support further growth, assuming new programs scale to profitable production. However, I concede their margins are worth monitoring going forward. This could ultimately limit how much of the sales growth reaches shareholders.